US › Healthcare

Vaxart Inc (VXRT)

US · Healthcare · Biotechnology

$0.60+1.69%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$39.2M
Revenue YoY
+87.9%
Net profit
$5.2M
Profit YoY
+133.2%
EPS
$0.02
EPS estimate
$0.02
Net margin
13.2%

EPS came in at 0.02 against a street estimate of 0.02 — a beat of 0.0%.

Key statistics

Market cap
$113.8M
P/E
2.9
Forward P/E
42.7
P/B
1.24
Book value
$0.39
EPS (TTM)
$0.16
52-week high
$0.84
52-week low
$0.31
50-day MA
$0.57
200-day MA
$0.55
Beta
1.09

Analyst view

Analysts rate Vaxart Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $3.33.

Shareholding

Insiders
1.39%
Institutions
0.06%

Largest institutional holders

FundStake
Heritage Wealth Advisors, LLC0.01%
LVM Capital Management Ltd.0.01%
ORG Partners LLC0.00%
Golden State Equity Partners0.00%
First Command Advisory Services, Inc.0.00%
Archer Investment Corporation0.00%
Concord Wealth Partners0.00%
Beacon Capital Management, LLC0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Vaxart Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.